As of 31 Dec 2025, 13 institutional investors reported holding 39,114 shares of Arcadia Biosciences, Inc. - COM (RKDA).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 39,114 | $77,444 | -$85,431 | $1.98 | 13 |
| 2025 Q3 | 65,469 | $227,175 | +$21,427 | $3.47 | 16 |
| 2025 Q2 | 59,229 | $259,133 | -$74,370 | $4.31 | 14 |
| 2025 Q1 | 76,493 | $222,115 | -$6,350 | $2.97 | 14 |
| 2024 Q4 | 78,535 | $464,928 | +$150,707 | $5.92 | 13 |
| 2024 Q3 | 53,913 | $149,017 | +$68,828 | $2.75 | 13 |
| 2024 Q2 | 28,701 | $90,408 | -$116,787 | $3.15 | 10 |
| 2024 Q1 | 80,957 | $178,327 | -$136,659 | $2.20 | 12 |
| 2023 Q4 | 138,529 | $430,741 | +$283,457 | $3.13 | 13 |
| 2023 Q3 | 47,444 | $158,572 | -$308,268 | $3.34 | 10 |
| 2023 Q2 | 138,672 | $538,046 | -$422,672 | $3.88 | 11 |
| 2023 Q1 | 161,885 | $1,209,095 | +$1,209,095 | $7.47 | 13 |